Tyson Foods to close major Nebraska beef plant amid cattle shortage - WSJ
Investing.com - Cantor Fitzgerald maintained its Neutral rating and $210.00 price target on Molina Healthcare (NYSE:MOH) stock in a research note released Wednesday. The analysis comes as healthcare sector peer CVS Health (NYSE: CVS) shows strong market presence with a $95.6 billion market cap and maintains a GOOD financial health score, according to InvestingPro data.
The firm highlighted Arizona as a state to monitor due to Medicaid disenrollment trends that could negatively impact Molina Healthcare and other health insurers including UnitedHealth, CVS Health, and Centene.
Arizona represents approximately 2% of Molina’s market share in the state and accounts for about 1% of the company’s total Medicaid enrollment, making it less exposed than competitors like CVS Health (15%), UnitedHealth (5%), and Centene (3%).
Cantor Fitzgerald noted that disenrollment in Arizona could potentially increase if the pending work requirement waiver, which completed its federal public comment period on May 9, 2025, receives approval from the Centers for Medicare & Medicaid Services.
The proposed waiver would apply to expansion adults aged 19-54 and includes provisions for an initial six-month grace period followed by a two-month coverage suspension for non-compliance.
In other recent news, CVS Health’s subsidiary Omnicare has filed for Chapter 11 bankruptcy protection following a $949 million judgment related to claims of improperly dispensing prescription drugs to long-term care patients. Omnicare’s bankruptcy filing in Texas lists assets of at least $100 million and liabilities ranging from $1 billion to $10 billion. Meanwhile, CVS Health is working to expand its Aetna Clinical Collaboration program to ten hospitals by the end of 2025, aiming to enhance support for Medicare Advantage members during hospital transitions. On the analyst front, Wolfe Research has raised its price target for CVS Health from $80 to $85, maintaining an Outperform rating, citing potential earnings growth through improved Medicare Advantage margins. Cantor Fitzgerald has also reiterated an Overweight rating on CVS Health, noting the company’s exposure to the Arizona market, where disenrollment trends are affecting several healthcare insurers. These developments provide a multifaceted view of CVS Health’s current business landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.